Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients
Athina Markou(National and Kapodistrian University of Athens), Evi Lianidou(Athens State University), Catherine Alix‐Panabières(Hamburg Institut (Germany)), Klaus Pantel(Universität Hamburg), Marifili Lazaridou(National and Kapodistrian University of Athens), Peter Sedlmayr(Medical University of Graz), Simon A. Joosse(Universität Hamburg), Andra Kuske(Universität Hamburg), Tobias M. Gorges(University Medical Center Hamburg-Eppendorf), M. Zabel(Poznan University of Medical Sciences), Shukun Chen(Northwest A&F University), Joanna Budna(Poznan University of Medical Sciences), Monika Świerczewska(Heliodor Swiecicki Clinical Hospital), Panagiotis Paraskevopoulos(National and Kapodistrian University of Athens), Thomas Kroneis(Medical University of Graz)
Cited by 76
Related Papers
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
|BMC Cancer|2012|561
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
|British Journal of Cancer|2020|402
Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells
|Developmental Cell|2018|328
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268